The serine/threonin kinase Aurora A is an oncoprotein, whereas von Hippel-Lindau protein (pVHL) is a tumor suppressor protein. Both proteins have the same localization during mitosis: in the mitotic spindle and the centrosome. These two proteins also have common functions, such as the regulation of the cell cycle, the stability of the mitotic spindle and both intervene in the functioning of centrosomes. In this study we have analyzed the interaction between Aurora A and pVHL with immunoprecipitation and in vitro phosphorylation experiments. We have confirmed that the immunoprecipitation of pVHL from Hek 293 cell extracts were coupled with Aurora A. In addition, the interaction between the two proteins has been tested by analyzing the phosphorylation of pVHL in vitro by Aurora A. The results revealed that pVHL was phosphorylated by Aurora A. In conclusion, the study demonstrated that Aurora A interacts with and phosphorylates pVHL. Given the role of these two proteins in cell division as well as their status in cancer, this interaction requires further investigation.
Introduction
Aurora A protein is a serine/threonine kinase which transfers the phosphate group from ATP to serine or threonine substrate residues during the phosphorylation reaction. This protein is a cell cycle regulated kinase and it plays an important role in the mitotic division. In fact during the late S phase it is located next to the duplicated centrosomes, where it is involved in their maturation (Meraldi & Nigg 2002) . In the G2 phase, it plays a role in the cell entry into mitosis (Cowley et al. 2009 ). Actually during prophase it is involved in the separation of centrosomes (Meraldi & Nigg 2002) . During prometaphase it migrates to the poles of the mitotic spindle where it participates in the assembly and the stability of the bipolar spindle through the control of the presence of astral microtubules by which the centrosomes are connected to cell cortex (Giet et al. 2002; Cowley et al. 2009 ). Later on and during metaphase it is involved in the setting up of the equatorial plate and the chromosomes alignment. Then in the anaphase and telophase, it localizes at the centrosomes and on the cleavage furrow to participate in cytokinesis (Carvajal et al. 2006; Fu et al. 2007) . Finally in the end of mitosis, Aurora A is ubiquitinated and therefore recognized by the 26S proteasome so this kinase is degraded through the ubiquitin-proteasome pathway anaphase-promoting complex (APC) -the major proteolytic system in the eukaryotic cell which involves a set of three proteins: (i) E1, an ubiquitin activating enzyme; (ii) E2, an ubiquitin conjugating enzyme; and (iii) E3, an ubiquitin ligase.
Aurora A is a key protein in cell division and many anomalies are attributed to its deregulation, such as genomic instability, aberrant duplication of the centrosomes and cell transformation. This protein is designated as an essential actor in aneuploidy. Given its important role in the process of cell cycle, its overexpression in several cancers (Ehara et al. 2003; Nadler et al. 2008; Loh et al. 2010) , its interaction with tumor suppressor and its involvement in the oncogenic signaling pathway, Aurora A protein is a promising protein in the cancer treatment.
A multitude of proteins has been identified as interacting with the Aurora A protein kinase such as the p53 protein, which is a transcription factor and a wellknown tumor suppressor inducing cell cycle arrest or cell apoptosis when DNA is damaged.
The pVHL exists in the cell under three isoforms. The gene VHL has three exons and is translated into the cell in three proteins: (i) the isoform 1 containing exons 1, 2 and 3 with the length of 213 amino acid residues and a molecular weight of 30 kDa (Kim et al. 2004) ; (ii) the isoform 2 containing only exons 1 and 3 corresponding to a protein with 173 residues with a molecular weight of about 24 kDa; and (iii) the isoform 3 that contains 161 residues with a size of 19 kDa differing from the isoform 1 by the absence of codons 1 to 54 as a result of an alternative initiation. The codons 14 to 53 correspond to the acid domain of the protein and encode eight copies of a pentamer GXEEX (Woodward et al. 2000) ; this region contains three serine in positions 33, 38 and 43 on which the protein can be phosphorylated by protein kinase CK2 (Lolkema et al. 2005; Ampofo et al. 2010) . The phosphorylation of pVHL affects the half-life of the protein, increases its stability and enhances the activity of p53 (a protein interactor with the pVHL). The interaction between pVHL and p53 protein involves the residues from 155 to 213 of pVHL including the β domain of this protein, which exists in the pVHL isoforms 2 (Lolkema et al. 2004) .
The pVHL protein has several functions. It is an E3 ubiquitin protein ligase involved in the ubiquitin proteasome pathway to degrade the endogenous proteins (E3 targets the protein substrates for specific degradation by the proteasome). This tumor suppressor controls also the cell cycle (Roe et al. 2006) , participates in the development and stability of the mitotic spindle (Hergovich et al. 2003; Lolkema et al. 2004 ) and mediates the functioning of centrosomes (Kuehn et al. 2007 ). The tumor suppressor pVHL plays a role in chromosome stability (Roe et al. 2006 ) and its absence increases aneuploidy. Moreover it is involved in the stabilization of the p53 protein (Roe et al. 2006 ) and regulates the tumor growth and cytokinesis (Thoma et al. 2009; Sinha et al. 2011) .
Based on a recent study in silico and in vitro that highlighted the interaction between Aurora A oncoprotein and the tumor suppressor pVHL (Ferchichi et al. 2010 ) and taking into account the property of Aurora A as a protein kinase, our aims in this work were to confirm the interaction between Aurora A and pVHL in vivo and to investigate whether pVHL protein is an Aurora A protein kinase substrate.
Material and methods

Cell lines and culture conditions
We have proceeded to the culture of the Hek 293 cell line derived from human embryonic kidney from ATCC (No. CRL-1573 American Type Culture Collection, USA). Cell line was cultured in DMEM medium (Dulbecco's Modified Eagle Medium, Invitrogen, UK) supplemented with 10% fetal bovine serum. Penicilline, streptomycine and fungizone (Invitrogen, UK) were added to the media. Cells were cultured at 37
• C in a humidified atmosphere with 5% CO2. Expanded up to 70-80% confluence cells were used for the experiments.
Antibodies
In this study we have used the following antibodies: monoclonal anti-pVHL (Neomarkers), polyclonal anti-pVHL (Santa Cruz) and monoclonal anti Aurora A (Sigma).
Endogenous immunoprecipitation assays
Cells were scratched in a lysis buffer: 50 mM Tris HCl (pH 8), 5 mM EDTA (pH 8), 1% NP 40, 300 mM sodium chloride, 10% sarcosyl and protease inhibitor cocktail containing 10 mM sodium fluoride, 0.2 mM sodium orthovanadate, 2 mM sodium pyrophosphate decahydrate and 2 mM β-glycerophosphate (Calbiochem, Germany). Then cell lysed samples were sonicated at 4
• C and centrifuged at 10,000 rpm for 10 min. Protein concentrations in the cell extracts were determined by the Bradford assay.
For immunoprecipitation, 100 µL of dynabeads protein-A (Dynal Biotech, France) were transferred into test tube at room temperature and washed twice with 500 µL of 0.1 M of sodium phosphate buffer, pH 8.1. Then beads were incubated for 10 min at room temperature on a wheel with 50 µL of antibody in the lysis buffer. After that beads were washed twice with 500 µL of 0.1 M sodium phosphate buffer (pH 8.1); later they were incubated with the cell extracts for 1 hour at room temperature on a wheel. This step was followed by beads wash with 1 mL phosphate buffered saline for three times. Bound proteins were eluted in 20 µL of Laemmli 2X β-mercaptoethanol and boiled at 95
• C for 5min. Finally, immunoprecipitates were subjected to 12.5% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a membrane and analyzed by Western blotting. For this experiment all buffers were prepared on test day.
Immunoblotting
Proteins in lysate were separated through a 15% SDS-PAGE, with a lane of SDS-PAGE molecular weight standards (low range, Biorad). The proteins were then blotted onto nitrocellulose membranes (Hybond Amersham). The membranes were blocked in 5% skim milk or bovine serum albumin in a TBS-T (150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 0.05% Tween 20) for 1 hour at room temperature. Then the first antibody in 2.5% skim milk or bovine serum albumin in a TBS-T was probed and after four washes in TBS-T, we have incubated for 1 hour at room temperature with peroxidase-conjugated rabbit or mouse (Jackson, Interchim) as secondary antibodies. Following three TBS-T washes, antibodies were detected by enhanced chemiluminescence ECL (Amersham Pharmacia Biotech) West Pico or West Dura (Pierce).
Plasmid construction, production and purification of proteins The construction of plasmid and the purification of proteins used in the kinase test have been performed as described previously by Ferchichi et al. (2010) .
In vitro kinase assay Briefly, we have incubated kinase buffer (500 mM TrisHCl, pH 7,5), triton 0.01%, 2 µCi (γ− 32 P) ATP, 100 µM ATP, 2 µg of substrate -GST-pVHL (isoform 2) (GST, glutathione S-transferase) or GST-Histone-3 -and 2 µg of (His)6-Aurora A kinase at 37
• C for 15 min. The reactions were stopped with the addition of Laemmli buffer and the samples were boiled at 100
• C for 5 min. The reaction products were resolved by 12.5% SDS-PAGE and 32 P incorporation was then analyzed by autoradiography.
This test was conducted simultaneously with controls containing the kinase with a known substrate (Histone H3), the kinase without any substrate and the substrate without the kinase. et al. (2010) have demonstrated both by a bioinformatics study in silico and using recombinants proteins in vitro that human Aurora A interacts with pVHL. In the present study we wanted to strengthen this confirmation by conducting in vivo experiments through testing endogenous proteins in a cell line. Seeing the property of Aurora A as a protein kinase we wanted to check whether the pVHL could be a substrate for Aurora A.
Results
Ferchichi
First, we started by verifying that the Hek 293 cells express both Aurora A and pVHL proteins. For this purpose we blotted cells extract with two antibodies directed, respectively, against one of the two studied molecules and obtained a single specific band at the expected size for each protein of interest. This result allowed us to show the usefulness of these two antibodies as well as the cell line Hek 293 to perform our further experiments.
A search for endogenous proteins interaction was performed by immunoprecipitation of the expected proteins complex from Hek 293 cell lysate using anti-pVHL antibody, followed by precipitated molecules analysis by Western blotting using separately anti-pVHL and anti-Aurora A antibodies. We confirmed the presence of these two proteins in the 'input' used in precipitation (Fig. 1) ; then we precipitated the pVHL with a polyclonal antibody, which recognizes the three isoforms of pVHL, but we blotted the precipitate, using a monoclonal antibody, which recognizes only isoforms 1 and 2 (it has been raised against the protein region encompassing amino acid residues 1-54 lacking in the isoform 3). At the expected size we found both pVHL isoforms recognized by our antibody and confirming thus that we precipitated the targeted isoforms, particularly the isoform 2, which has an approximate size of 24 kDa. Then we blotted the precipitate with Aurora A antibody and found at the expected size two specific bands corresponding respectively to non-phosphorylated Aurora A and phosphorylated Aurora A. As shown in Figure 2 , the in vivo interaction between Aurora A and pVHL investigated by immunoprecipitation followed by Western blotting involves as well non-phosphorylated Aurora A and phosphorlyated Aurora A, the active kinase.
After finding out the physical interaction between Aurora A kinase and pVHL, we aimed in the next experiment to check whether this kinase could phosphorylate pVHL. In this perspective recombinant proteins: (His) 6 -Aurora A, GST-pVHL and GST-Histone-3 were generated. The (His) 6 -Aurora A protein was incubated without any other protein (Fig. 3, lane 3) , with GST- H3 as a positive control (Fig. 3, lane 1) and with GSTpVHL protein (Fig. 3, lane 2) . For negative control, we used GST-pVHL without (His) 6 -Aurora A. In each sample, labeled ATP was added and incorporation of radioactivity was carried out after SDS-PAGE and autoradiography.
The incorporation of radioactivity within Aurora A incubated alone indicates that the protein autophosphorylation in vitro leading to the active Aurora A kinase. Furthermore, since the incorporation of radioactivity in the GST-pVHL recombination is observed in the presence of (His) 6 -Aurora A and not in its absence, this phosphorylation assay reveals that the recombinant Aurora A protein, with spontaneously generated kinase activity, phosphorylates the GST-pVHL protein in vitro, suggesting thus that the pVHL could be a substrate for Aurora A.
Discussion
In a previous study (Ferchichi et al. 2010) , we evaluated the possibility that the tumor suppressor protein pVHL and the oncogenic protein Aurora A kinase could interact, and we have sustained this confirmation by testing the interaction of these proteins in vitro. In the current study, using cells extracts, we provide by immunoprecipitation further evidence that pVHL physically interacts with Aurora A in vivo. Indeed, immunoprecipitation performed using specific anti pVHL antibody not only allowed the capture of the autologous antigen from cells lysate, but also Aurora A. This result suggests that this latter protein has been indirectly immunoprecipitated due to its presence along with pVHL in molecular complexes naturally assembled within the cells. This molecular interaction seems to lead to several functional effects.
In order to better characterize the relationship between these two proteins, and based on the fact that the phosphorylated Aurora A displays kinase activity, we tried to demonstrate that Aurora A kinase phosphorylates the pVHL protein as a substrate.
For the construction of the pVHL recombinant protein we have chosen a tag, which is not a substrate of the Aurora A protein and so we selected the GST. Thus if the GST-pVHL protein is phosphorylated, it will be possible only in the pVHL part. And for the purpose of the phosphorylation positive control test, we used Histone 3 protein, a well-known substrate of Aurora A (Crosio et al. 2002) , while for the negative control we opted for the GST-pVHL protein without Aurora A. An additional lane was used with only the Aurora A kinase for the purpose of verification that the protein is activated by its autophosphorylation (Marumoto et al. 2005) and to identify the corresponding band in order to disregard it during the kinase test involving the Aurora A and pVHL.
Results of the in vitro experiments using recombinant proteins suggested that Aurora A would be able to undergo spontaneous autophosphorylation generating active Aurora A kinase that would in its turn phosphorylate GST-H3 or GST-pVHL recombinant proteins. In fact, it has already been demonstrated that Histone 3 was a substrate for Aurora A kinase and we suggest that it would also be the case for pVHL. The phosphorylation of pVHL by Aurora A kinase may affect its half-life and increase its stability.
The phosphorylation of pVHL by Aurora A does not exclude the existence of other types of interaction between these two proteins. Indeed, since Aurora A protein is degraded by the ubiquitin proteasome and since pVHL is a component of this pathway, we suggest that pVHL could be involved in the degradation of this kinase. Hence, we propose that active Aurora A kinase would increase the stability of pVHL, which in its turn would participate in the degradation of the former protein. Thus, this phosphorylation could initiate the one of Aurora A by pVHL.
Previous studies reported that Aurora A and pVHL have a common location on the mitotic spindle during mitosis and are involved in common biological features. Both proteins participate in the stability of the mitotic spindle and in centrosomes separation. Dysfunction of each of these proteins is responsible for aneuploidy. Moreover both pVHL and Aurora A were shown to interact, respectively, with the p53 protein, a cell cycle regulator p53 protein (Roe et al. 2006) . In addition, their presence in molecular complexes together with the tumor suppressor protein p53 would also be related by another way to their involvement in cell cycle progression and tumorigenesis (Fu et al. 2007 ). Hence, their common location, their involvement in common functions, their interaction with common molecules are in agreement with the direct interaction of Aurora A with pVHL established in the present study. Our findings inspire us for further investigations to determine the functional interaction between pVHL and Aurora A.
